Relay Therapeutics, Inc. RLAY Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeOther.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s interest income?
- Relay Therapeutics, Inc. (RLAY) reported interest income of $5.35M in Q1 2026.
- How has Relay Therapeutics, Inc.'s interest income changed year-over-year?
- Relay Therapeutics, Inc.'s interest income decreased by 31.5% year-over-year, from $7.81M to $5.35M.
- What is the long-term trend for Relay Therapeutics, Inc.'s interest income?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s interest income has grown at a 138.9% compound annual growth rate (CAGR), from $830K to $27.04M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.